TRACK D - Medical Device & Digital Health:
Putting Data into the Patient's Hands
Innovations and clinical advancements are enabling more genetic insights than ever before. Keeping up with the level of innovation around precision medicine is no easy feat. More than 74,000 genetic tests and testing products are on the market, with more than 10 new test released each day. Join us for a discussion around how the data is overload our providers and making it difficult to interpret, while also empowering the patient by giving them a new look into their data.
Founder and Managing Director, Accendo
Advisor, Red Sky Partners
Alice Pomponio is a systems-level strategist, creator, and convener with over twenty years of experience in life sciences industry, public policy, and community nonprofit. Recognized for her broad and deep technical knowledge and out-of-the-box thinking, Alice is a trusted advisor to organizations and coalitions embarking on internal and external transformation in life sciences and healthcare. In 2018, Alice founded Accendo to accelerate entrepreneurial consumer-facing approaches to patient access and affordability to quality care. She advises high growth life sciences companies on patient centricity and product planning strategies as an advisor at Red Sky Partners. She has held prior strategy and operational leadership roles at Radius Health, AstraZeneca, and Sanofi Genzyme where she launched multiple US and global specialty products and championed passage of orphan drug policy across the globe. Her public sector experience spans across innovation, trade, and healthcare policy through roles in the UK Government and US Office of Management and Budget. Alice holds a Master of Public Policy from Harvard University and a Bachelor of Science in Biology from MIT. She currently serves on the Boards of Massachusetts Biotechnology Council, MassEcon, American Cancer Society Eastern New England, ACS BrightEdge, ACS CAN, and PhagePro Inc.
Michael Levy, MBA
CEO & Co-Founder, Bluedoor
President & Co-Founder, Digital Health Institute for Transformation
Michael Levy is a purpose-driven problem-solver, uniting and collaborating with like-minded people to support impact and transformation in healthcare and education. Michael is a healthcare executive turned entrepreneur with a digitally-enabled mindset. Earning his BS in Neurobiology from Tulane University and his MBA from Elon University, coupled with high technology literacy from his experience at Apple at the turn of the century, he is on a path to unite process, people, and technology to create a new cultural operating system for the 21st century. That is why Michael co-founded Bluedoor and the Digital Health Institute for Transformation (DHIT). In partnership, Bluedoor and DHIT serve as the vehicles to Michael's vision and the operating entities to drive impact and transformation into communities.
Anju Mathew, MBA
Co-Founder & CEO, OncoLens
Anju Mathew is CEO and co-founder of OncoLens. Most recently, she was the head of technology and innovation at McKesson’s Medical Surgical business unit where she led the development and launch of several successful tools and business partnerships positioned to take cost out of our healthcare system.
Prior to her role at McKesson Medical Surgical, Anju was part of McKesson’s corporate strategy group. She was also co-founder and executive at LumaMed, a medical device company focused on cancer imaging. Prior to LumaMed, she worked with Thomson-Reuters, A. T. Kearney, IBM and i2 Technologies.
Anju has an MBA from Northwestern University’s Kellogg School of Management and Bachelor’s in Industrial Engineering from the Indian Institute of Technology. She is a member of the Atlanta Technology Angels group and a member of the board of directors for Illuma Care Connections, headquartered in Atlanta.
In her free time, Anju enjoys spending time with her husband, son, daughter and dog, Lexi. She enjoys going on long walks, watching movies and traveling around the world.
Ashley L. Reynolds, PhD, RN, ACSM-HFS
Chief Experience Officer, BioIQ
Dr. Ashley Reynolds currently serves as BioIQ's Chief Experience Officer. In his role, he will oversee areas that impact the member and client journey. Dr. Reynolds brings to BioIQ over 26 years of healthcare experience. As a healthcare executive, Dr. Reynolds has proven his operational and population health expertise leading large regional territories and multiple departments within health plan, disease management, health technology and wellness companies.
An expert in the area of e-Health and wireless technologies as tools for behavior change as well as the age-related differences in their adoption, Dr. Reynolds has published on the effectiveness of “virtual” coaches to reduce health risks. Dr. Reynolds is a frequent national speaker on health, wellness, technology-mediated health behavior and the use of digital coaching tools to improve health and has guided the development of awarding winning mobile health applications. Dr. Reynolds has also participated in several industry leading committees including: CDC/NIH diabetes health sense task force, Digital Health Council for the Society for Behavioral Medicine, Population Health Alliance (PHA) engagement committee, and Technology engagement subcommittee. He is also a frequent peer reviewer on the topic of technology and health for the Society for Behavioral Medicine.
Dr. Reynolds is a registered nurse and is certified by the American College of Sports Medicine as a health and fitness specialist. He is a member of the Society for Behavioral Medicine and the American College of Sports Medicine. Dr. Reynolds holds a PhD in Nursing Science, with a minor in health behavior from the University of Florida and a Bachelor and Master of Science in nursing from Jacksonville University.
Senior VP, Cancer Control Programs and Services, American Cancer Society
Chuck is a digital media veteran who came to the American Cancer Society to further its work in empowering people to improve their health outcomes. His department is responsible for providing information on multiple platforms including cancer.org and providing the strategy and operations for its online patient community, Cancer Survivors Network. He also leads a 24/7 contact center and the teams responsible for providing free transportation and lodging. Prior to ACS, Chuck was a Senior VP and Managing Editor at CNN.com responsible for domestic and international editorial staff including the teams managing hundreds of topical message boards.